Treace Medical Concepts Cash Flow Statement (2020-2026) | TMCI

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-236.75M-199.46M-6.58M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Share-based Compensation (Quarter)
0.88M0.84M-2.12M1.41M1.96M2.27M2.47M2.69M3.60M5.19M5.88M7.41M6.74M7.90M8.55M8.69M9.58M8.00M-25.37M8.03M
Asset Writedowns and Impairment (Quarter)
0.16M0.03M-0.23M0.16M0.45M0.04M0.04M0.00M0.35M0.16M2.05M0.17M0.57M0.50M0.08M-0.07M
Cash from Operations (Quarter)
-3.73M-9.26M-3.75M-7.24M-10.56M-7.49M-5.36M-17.26M-8.34M-9.51M0.53M-7.22M-13.90M-11.84M-4.21M4.20M-3.05M-9.09M-8.03M7.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.13M0.30M0.37M0.37M0.38M0.34M0.35M0.23M0.23M0.08M0.04M0.01M0.00M-0.01M
Amortization of Deferred Charges (Quarter)
0.04M0.04M0.04M0.04M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.26M
Depreciation & Amortization (CF) (Quarter)
0.10M0.20M0.28M0.33M0.40M0.40M0.92M0.92M1.10M1.56M1.77M1.91M2.12M2.16M2.24M2.46M2.58M2.78M2.81M0.90M
Change in Working Capital
Change in Receivables (Quarter)
-0.74M1.76M6.97M-2.54M0.43M2.05M11.10M-3.79M1.91M-2.23M13.42M-7.82M-2.48M-1.21M17.19M-9.29M-0.70M2.56M9.52M-11.69M
Change in Inventory (Quarter)
0.39M2.80M0.03M0.55M1.86M3.62M2.74M3.19M3.52M3.21M-0.07M6.62M5.42M2.33M-4.36M-1.31M4.46M-0.97M-5.39M0.34M
Change in Account Payables (Quarter)
1.83M-0.48M1.61M-0.61M-0.35M4.78M0.79M-3.59M3.07M0.53M3.15M9.31M-3.08M0.58M-8.13M2.70M6.74M-3.86M-9.38M6.81M
Change in Accured Expenses (Quarter)
0.57M1.34M5.87M-2.62M1.66M4.07M4.01M-4.08M0.94M1.18M9.48M-6.92M0.97M-6.81M4.85M-6.17M0.86M2.12M0.78M-3.13M
Other Working Capital Changes (Quarter)
2.54M0.25M-0.75M-1.23M2.27M0.02M-0.39M0.96M0.68M-0.61M0.18M1.50M-1.68M-0.65M-1.35M-1.37M1.28M0.61M-0.70M-0.61M
Investing Activities
Capital Expenditures (Quarter)
0.67M-0.87M1.48M5.17M-6.79M14.98M1.48M4.23M-5.71M11.46M0.31M0.02M3.54M-3.18M-0.06M13.21M0.29M
Change in Acquisitions & Divestments (Quarter)
1.73M20.55M35.22M27.22M37.05M36.40M24.16M32.80M25.18M16.74M16.67M16.18M17.75M11.32M
Cash from Investing Activities (Quarter)
-0.67M-0.94M-0.90M-1.48M-5.17M-5.86M-64.01M-80.48M-10.42M4.60M5.01M3.76M22.43M5.76M3.42M-1.89M-3.26M8.74M9.67M-7.82M
Financing Activities
Other financing activities (Quarter)
0.19M106.85M-105.78M1.37M0.17M0.35M-1.89M107.53M-105.84M105.84M0.05M0.31M0.01M-0.37M0.12M0.12M0.24M-0.48M0.09M
Cash from Financing Activities (Quarter)
107.80M0.04M1.03M1.37M18.78M0.35M0.30M107.88M1.18M0.16M0.17M-0.18M0.31M0.01M0.03M-0.28M0.99M-0.01M1.38M-0.59M
Additional items
Change in Cash (Quarter)
103.40M-10.16M-3.63M-7.35M3.05M-12.99M-69.07M10.14M-17.58M-4.76M5.70M-3.65M8.85M-6.07M-0.76M2.02M-5.32M-0.37M3.02M-1.16M
Free Cash Flow (Quarter)
-4.40M-8.40M-3.75M-8.72M-15.73M-0.69M-20.34M-18.74M-12.57M-3.80M-10.93M-7.22M-13.90M-12.15M-4.22M0.66M0.13M-9.03M-21.24M6.95M
Net Cash Flow (Quarter)
103.40M-10.16M-3.63M-7.35M3.06M-12.99M-69.07M10.14M-17.58M-4.76M5.70M-3.65M8.85M-6.07M-0.76M2.02M-5.32M-0.37M3.02M-1.16M